Mišo Šabovič

4PUBLICATIONS
7CO-AUTHORS
Food properties (incl. characteristics and health benefits)Structure and dynamics of materialsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 04, 2025
Rosuvastatin Improved LDL Subfractions Profile in a Patient with Type 1 Diabetes Following a Ketogenic Diet: A Case Report.

Miodrag Janić, Mojca Lunder, Andrej Janež

|Nov 27, 2024
Glucometabolic Efficacy of the Empagliflozin/Metformin Combination in People with Type 1 Diabetes and Increased Cardiovascular Risk: A Sub-Analysis of a Pilot Randomized Controlled Trial.

Miodrag Janić, Andrej Janež, Mišo Šabović

|Feb 25, 2023
Inflammatory, Metabolic, and Coagulation Effects on Medial Arterial Calcification in Patients with Peripheral Arterial Disease.

Jovana Nikolajević, Mišo Šabovič

|May 27, 2022
Empagliflozin-Metformin Combination Has Antioxidative and Anti-Inflammatory Properties that Correlate with Vascular Protection in Adults with Type 1 Diabetes.

Miodrag Janić, Matej Cankar, Jan Šmid

Pageof 1

Frequent Collaborators

3 joint publications

Miodrag Janić

3 joint publications

Andrej Janež

2 joint publications

Mojca Lunder

2 joint publications

Manfredi Rizzo